-- Sichuan Biokin Pharmaceutical's (SHA:688506) attributable net loss ballooned to 774.6 million yuan in the first quarter from 531.4 million yuan a year earlier.
Loss per share likewise widened to 1.88 yuan from 1.33 yuan, the pharmaceutical company said in a Shanghai bourse filing on Tuesday.
Revenue, however, jumped 40% to 94.6 million yuan from 67.4 million yuan, which Biokin attributed to increased market demand for its products.
Shares of the company fell nearly 3% in recent trade.
Bio Port Korea (KOSDAQ:188040) posted first-quarter net income of 710 million won, rebounding from a net loss of 34 million won a year earlier, according to a Tuesday filing with the Korea Exchange.The South Korean health functional foods company's sales revenue jumped 27% year over year to 21.4 billion won from 16.9 billion won.Shares of Bio Port Korea rose more than 2% in recent trade.
Jiangsu Yanghe Brewery (SHE:002304) posted 2025 attributable net profit of 2.21 billion yuan, down 67% from 6.67 billion yuan the previous year.Earnings per share fell to 1.4644 yuan from 4.4299 yuan, according to a Tuesday filing with the Shenzhen bourse.The liquor company's revenue declined 33% year over year to 19.2 billion yuan from 28.9 billion yuan.
Resolution Minerals (ASX:RML) produced concentrates of 52.3% tungsten trioxide via preliminary gravity separation test work on tungsten composite samples, assaying 1.85% grade of tungsten trioxide, from stockpiles at the Johnson Creek mill site, sourced from the historical mining at the Golden Gate tungsten mine in Idaho, according to a Tuesday Australian bourse filing.Heavy liquid separation scoping tests on the tungsten composite samples achieved a grade of 52.3% of tungsten trioxide with a recovery of 75.5%.Its shares rose 4% in recent trading on Tuesday.